TY - JOUR
T1 - Ocular Biometric Risk Factors for Progression of Primary Angle Closure Disease
T2 - The Zhongshan Angle Closure Prevention Trial
AU - Xu, Benjamin Y.
AU - Friedman, David S.
AU - Foster, Paul J.
AU - Jiang, Yu
AU - Porporato, Natalia
AU - Pardeshi, Anmol A.
AU - Jiang, Yuzhen
AU - Munoz, Beatriz
AU - Aung, Tin
AU - He, Mingguang
N1 - Funding Information:
Supported by the National Eye Institute, National Institutes of Health , Bethesda, Maryland (grant no.: K23 EY029763 ); the American Glaucoma Society (Young Clinician Scientist Research Award); the Southern California Clinical and Translational Science Institute, Los Angeles, California (SC-CTSI Clinical and Community Research Award); and Research to Prevent Blindness, Inc, New York (unrestricted grant to the Department of Ophthalmology). The ZAP Trial was supported by Fight for Sight (grant no.: 1655 ; United Kingdom); Sun Yat-sen University 5010 Project Fund (grant no.: 2007033 ; China); the National Natural Science Foundation of China (grant no.: 81420108008 ; China); the State Key Laboratory in Ophthalmology (Fundamental Research Funds; China); and Moorfields Eye Charity (previously Special Trustees of Moorfields Eye Hospital), London, United Kingdom.
Publisher Copyright:
© 2021 American Academy of Ophthalmology
PY - 2022/3
Y1 - 2022/3
N2 - Purpose: To assess baseline ocular biometric risk factors for progression from primary angle closure suspect (PACS) to primary angle closure (PAC) or acute angle closure (AAC). Design: Prospective, observational study. Participants: Six hundred forty-three mainland Chinese with untreated PACS. Methods: Participants underwent baseline clinical examinations, including gonioscopy, anterior segment OCT (AS-OCT) imaging, and A-scan ultrasound biometry as part of the Zhongshan Angle Closure Prevention (ZAP) Trial. Primary angle closure suspect was defined as an inability to visualize pigmented trabecular meshwork in 2 or more quadrants based on static gonioscopy. Primary angle closure was defined as development of intraocular pressure above 24 mmHg or peripheral anterior synechiae. Progression was defined as development of PAC or an AAC attack. Multivariable logistic regression models were developed to assess biometric risk factors for progression. Main Outcome Measures: Six-year progression from PACS to PAC or AAC. Results: Six hundred forty-three untreated eyes (609 nonprogressors, 34 progressors) of 643 participants were analyzed. In a multivariable model with continuous parameters, narrower horizontal angle opening distance of 500 μm from the scleral spur (AOD500; odds ratio [OR], 1.10 per 0.01-mm decrease; P = 0.03), flatter horizontal iris curvature (IC; OR, 1.96 per 0.1-mm decrease; P = 0.01), and older age (OR, 1.11 per 1-year increase; P = 0.01) at baseline were associated significantly with progression (area under the receiver operating characteristic curve [AUC], 0.73). Smaller cumulative gonioscopy score was not associated with progression (OR, 1.03 per 1-modified Shaffer grade decrease; P = 0.85) when replacing horizontal AOD500 in the multivariable model. In a separate multivariable model with categorical parameters, participants in the lowest quartile of horizontal AOD500 (OR, 3.10; P = 0.002) and IC (OR, 2.48; P = 0.014) measurements and 59 years of age or older (OR, 2.68; P = 0.01) at baseline showed higher odds of progression (AUC, 0.72). Conclusions: Ocular biometric measurements can help to risk-stratify patients with early angle closure for more severe disease. Anterior segment OCT measurements of biometric parameters describing the angle and iris are predictive of progression from PACS to PAC or AAC, whereas gonioscopy grades are not.
AB - Purpose: To assess baseline ocular biometric risk factors for progression from primary angle closure suspect (PACS) to primary angle closure (PAC) or acute angle closure (AAC). Design: Prospective, observational study. Participants: Six hundred forty-three mainland Chinese with untreated PACS. Methods: Participants underwent baseline clinical examinations, including gonioscopy, anterior segment OCT (AS-OCT) imaging, and A-scan ultrasound biometry as part of the Zhongshan Angle Closure Prevention (ZAP) Trial. Primary angle closure suspect was defined as an inability to visualize pigmented trabecular meshwork in 2 or more quadrants based on static gonioscopy. Primary angle closure was defined as development of intraocular pressure above 24 mmHg or peripheral anterior synechiae. Progression was defined as development of PAC or an AAC attack. Multivariable logistic regression models were developed to assess biometric risk factors for progression. Main Outcome Measures: Six-year progression from PACS to PAC or AAC. Results: Six hundred forty-three untreated eyes (609 nonprogressors, 34 progressors) of 643 participants were analyzed. In a multivariable model with continuous parameters, narrower horizontal angle opening distance of 500 μm from the scleral spur (AOD500; odds ratio [OR], 1.10 per 0.01-mm decrease; P = 0.03), flatter horizontal iris curvature (IC; OR, 1.96 per 0.1-mm decrease; P = 0.01), and older age (OR, 1.11 per 1-year increase; P = 0.01) at baseline were associated significantly with progression (area under the receiver operating characteristic curve [AUC], 0.73). Smaller cumulative gonioscopy score was not associated with progression (OR, 1.03 per 1-modified Shaffer grade decrease; P = 0.85) when replacing horizontal AOD500 in the multivariable model. In a separate multivariable model with categorical parameters, participants in the lowest quartile of horizontal AOD500 (OR, 3.10; P = 0.002) and IC (OR, 2.48; P = 0.014) measurements and 59 years of age or older (OR, 2.68; P = 0.01) at baseline showed higher odds of progression (AUC, 0.72). Conclusions: Ocular biometric measurements can help to risk-stratify patients with early angle closure for more severe disease. Anterior segment OCT measurements of biometric parameters describing the angle and iris are predictive of progression from PACS to PAC or AAC, whereas gonioscopy grades are not.
KW - Angle closure glaucoma
KW - Anterior segment OCT
KW - Disease progression
KW - Ocular biometrics
KW - Primary angle closure
KW - Risk stratification
UR - http://www.scopus.com/inward/record.url?scp=85118263417&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85118263417&partnerID=8YFLogxK
U2 - 10.1016/j.ophtha.2021.10.003
DO - 10.1016/j.ophtha.2021.10.003
M3 - Article
C2 - 34634364
AN - SCOPUS:85118263417
SN - 0161-6420
VL - 129
SP - 267
EP - 275
JO - Ophthalmology
JF - Ophthalmology
IS - 3
ER -